Novo Nordisk invests $1.2bn in new Denmark facility
Denmark-based pharma giant Novo Nordisk has announced plans to invest DKr8.5bn ($1.2bn) to establish a new production facility in Odense,…
Consumer Trends
-
-
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
In an open letter, 77 Nobel laureates have “strongly” urged members of the US Senate to reject Donald Trump’s nomination…
-
Vifor Pharma offers £23m to NHS to resolve CMA investigation
The UK’s Competition and Markets Authority (CMA) has received a £23m ($29m) offer from Vifor Pharma for the NHS to…
-
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Having promised to “Make America Healthy Again”, the administration in Trump’s second presidency looks set to shake up the health…
-
Dr Oz nominated to lead CMS despite big pharma ties
Television personality Dr Mehmet Oz has been nominated by President-elect Donald Trump to lead the Centers for Medicare and Medicaid…
-
FDA approves Journey Medical’s rosacea treatment Emrosi
The US’ Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi, the brand name for its 40mg minocycline hydrochloride…
-
NCCN visits Vietnam in continued cancer care collaboration
Leaders from the National Comprehensive Cancer Network (NCCN) alliance of US cancer centres are in Vietnam today (1 November) as…
-
Reeves’ 2024 budget promises life sciences investment
Announcing the UK's Budget yesterday (30 October), Rachel Reeves outlined the Labour Party’s investment plans for research and development (R&D)…
-
Bladder cancer diagnoses to top 300,000 in major markets by 2033
The number of incident cases of bladder cancer in the eight major markets is set to increase, with men and…
-
UPFs fuelling ‘alarming rise of chronic diseases’ in india
A surge in obesity levels in India has raised concerns about the prominence of ultra-processed foods (UPF), which research has…
